Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression

Toxicology and Applied Pharmacology

Volumn 195, Issue 3, 2004, Pages 331-338

  Ramos, Gerardo ^a,b   Kazimi, Nasser ^a   Nghiem, Dat X ^a,b   Walterscheid, Jeffrey P ^a,b   Ullrich, Stephen E ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Beta hydroxy toluene; BHT; c PAF; Carbamyl platelet activating factor; Commercial jet fuel; Delayed type hypersensitivity; DTH; Immune suppression; Jet fuel; Jet propulsion 8 military jet fuel; Jet A; JP 8; Oct Br.; Platelet activating factor; Prostaglandins

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CYCLOOXYGENASE 2; FUEL; PHOSPHOLIPID; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TOLUENE DERIVATIVE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG SELECTIVITY; DRUG SPECIFICITY; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; RECEPTOR BINDING; UPREGULATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ASCORBIC ACID; CELL LINE; DINOPROSTONE; FEMALE; HYDROCARBONS; HYPERSENSITIVITY, DELAYED; KERATINOCYTES; MICE; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; VITAMIN E;

EID: 1542407663     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.07.014     Document Type: Article

References (37)

1. Andrews J., Halliday G.M., Muller H.K. A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice. Clin. Exp. Immunol. 85:1991;9-13.
2. Boulares A.H., Contreras F.J., Espinoza L.A., Smulson M.E. Roles of oxidative stress and glutathione depletion in JP-8 jet fuel-induced apoptosis in rat lung epithelial cells. Toxicol. Appl. Pharmacol. 180:2002;92-99.
3. Corey E.J., Chen C.P., Parry M.J. Dual binding modes to the receptor for platelet activating factor (PAF) of anti-PAF trans-2,5-diarylfurans. Tetrahedron Lett. 29:1988;2899-2902.
4. Davies S.S., Pontsler A.V., Marathe G.K., Harrison K.A., Murphy R.C., Hinshaw J.C., Prestwich G.D., Hilaire A.S., Prescott S.M., Zimmerman G.A., McIntyre T.M. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J. Biol. Chem. 276:2001;16015-16023.
5. Fernandez-Gallardo S., Ortega M.P., Priego J.G., de Casa-Juana M.F., Sunkel C., Sanchez Crespo M. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies. J. Pharmacol. Exp. Ther. 255:1990;34-39.
6. Grant G.M., Jackman S.M., Kolanko C.J., Stenger D.A. JP-8 jet fuel-induced DNA damage in H4IIE rat hepatoma cells. Mutat. Res. 490:2001;67-75.
7. Harris D.T., Sakiestewa D., Robledo R.F., Witten M. Immunotoxicological effects of JP-8 jet fuel exposure. Toxicol. Ind. Health. 13:1997;43-55.
8. Harris D.T., Sakiestewa D., Robledo R.F., Witten M. Protection from JP-8 jet fuel induced immunotoxicity by administration of aerosolized substance P. Toxicol. Ind. Health. 13:1997;571-588.
9. Harris D.T., Sakiestewa D., Robledo R.F., Witten M. Short-term exposure to JP-8 jet fuel results in long-term immunotoxicity. Toxicol. Ind. Health. 13:1997;559-570.
10. Harris D.T., Sakiestewa D., Robledo R.F., Young R.S., Witten M. Effects of short-term JP-8 jet fuel exposure on cell-mediated immunity. Toxicol. Ind. Health. 16:2000;78-84.
11. Hays A.M., Parliman G., Pfaff J.K., Lantz R.C., Tinajero J., Tollinger B., Hall J.N., Witten M.L. Changes in lung permeability correlate with lung histology in a chronic exposure model. Toxicol. Ind. Health. 11:1995;325-336.
12. Ishii S., Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39:2000;41-82.
13. Kinkead E.R., Salins S.A., Wolfe R.E. Acute irritation and sensitization potential of JP-8 jet fuel. Acute Toxic. Data. 11:1992;700.
14. Lewis M.S., Whatley R.E., Cain P., McIntyre T.M., Prescott S.M., Zimmerman G.A. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J. Clin. Invest. 82:1988;2045-2055.
15. Marathe G.K., Davies S.S., Harrison K.A., Silva A.R., Murphy R.C., Castro-Faria-Neto H., Prescott S.M., Zimmerman G.A., McIntyre T.M. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J. Biol. Chem. 274:1999;28395-28404.
16. Mattie D.R., Alden C.L., Newell T.K., Gaworski C.L., Flemming C.D. A 90-day continuous vapor inhalation toxicity study of JP-8 jet fuel followed by 20 or 21 months of recovery in Fischer 344 rats and C57BL/6 mice. Toxicol. Pathol. 19:1991;77-87.
17. Mattie D.R., Marit G.B., Flemming C.D., Cooper J.R. The effects of JP-8 jet fuel on male Sprague-Dawley rats after a 90-day exposure by oral gavage. Toxicol. Ind. Health. 11:1995;423-435.
18. McDougal J.N., Pollard D.L., Weisman W., Garrett C.M., Miller T.E. Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol. Sci. 55:2000;247-255.
19. McIntyre T.M., Zimmerman G.A., Prescott S.M. Biologically active oxidized phospholipids. J. Biol. Chem. 274:1999;25189-25192.
20. Monteiro-Riviere N., Inman A., Riviere J. Effects of short-term high-dose and low-dose dermal exposure to Jet A, JP-8 and JP-8 + 100 jet fuels. J. Appl. Toxicol. 21:2001;485-494.
21. Pei Y., Barber L.A., Murphy R.C., Johnson C.A., Kelley S.W., Dy L.C., Fertel R.H., Nguyen T.M., Williams D.A., Travers J.B. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J. Immunol. 161:1998;1954-1961.
22. Pfaff J., Parton K., Lantz R.C., Chen H., Hays A.M., Witten M.L. Inhalation exposure to JP-8 jet fuel alters pulmonary function and substance P levels in Fischer 344 rats. J. Appl. Toxicol. 15:1995;249-256.
23. Prescott S.M., Zimmerman G.A., Stafforini D.M., McIntyre T.M. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69:2000;419-445.
24. Ramos G., Nghiem D.X., Walterscheid J.P., Ullrich S.E. Dermal application of jet fuel suppresses secondary immune reactions. Toxicol. Appl. Pharmacol. 180:2002;136-144.
25. 2 release. Burns. 27:2001;215-218.
26. 2 in combination. J. Invest. Dermatol. 117:2001;880-885.
27. Robledo R.F., Young R.S., Lantz R.C., Witten M.L. Short-term pulmonary response to inhaled JP-8 jet fuel aerosol in mice. Toxicol. Pathol. 28:2000;656-663.
28. Rogers J.V., Gunasekar P.G., Garrett C.M., Kabbur M.B., McDougal J.N. Detection of oxidative species and low-molecular-weight DNA in skin following dermal exposure with JP-8 jet fuel. J. Appl. Toxicol. 21:2001;521-525.
29. Rys-Sikora K.E., Konger R.L., Schoggins J.W., Malaviya R., Pentland A.P. Coordinate expression of secretory phospholipase A-2 and cyclooxygenase-2 in activated human keratinocytes. Am. J. Physiol., Cell Physiol. 278:2000;C822-C833.
30. Schwacha M.G., Chung C.S., Ayala A., Bland K.I., Chaudry I.H. Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury. Am. J. Physiol., Cell Physiol. 282:2002;C263-C270.
31. 2, interleukin-4, and interleukin-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160:1998;3783-3789.
32. Smith L.B., Bhattacharya A., Lemasters G., Succop P., Puhala E. II, Medvedovic M., Joyce J. Effect of chronic low-level exposure to jet fuel on postural balance of US Air Force personnel. J. Occup. Environ. Med. 39:1997;623-632.
33. Terashita Z., Imura Y., Nishikawa K. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet. Biochem. Pharmacol. 34:1985;1491-1495.
34. Ullrich S.E. Dermal application of JP-8 jet fuel induces immune suppression. Toxicol. Sci. 52:1999;61-67.
35. Ullrich S.E., Lyons H.J. Mechanisms involved in the immunotoxicity induced by dermal application of JP-8 jet fuel. Toxicol. Sci. 58:2000;290-298.
36. Walterscheid J.P., Ullrich S.E., Nghiem D.X. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 195:2002;171-179.
37. White R.D. Refining and blending of aviation turbine fuels. Drug Chem. Toxicol. 22:1999;143-153.